Recent studies have demonstrated that the development of DR in patients with type 1 diabetes is associated with the occurrence of polymorphisms at the 5'-end of the aldose reductase gene (ALR2). The gene discussed is AKR1B1; the disease is type 1 diabetes mellitus.